67
Focus on Sepsis Livio Pagano Istituto di Ematologia-Polo di Onco-Ematologia Fondazione Policlinico Agostino Gemelli Università Cattolica S. Cuore Roma

Focus on Sepsis - SEIFEM

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Focus on Sepsis - SEIFEM

FocusonSepsis

LivioPaganoIstitutodiEmatologia-PolodiOnco-Ematologia

FondazionePoliclinicoAgostinoGemelliUniversitàCattolicaS.Cuore

Roma

Page 2: Focus on Sepsis - SEIFEM
Page 3: Focus on Sepsis - SEIFEM
Page 4: Focus on Sepsis - SEIFEM
Page 5: Focus on Sepsis - SEIFEM
Page 6: Focus on Sepsis - SEIFEM
Page 7: Focus on Sepsis - SEIFEM

SurvivingSepsisandSepticShock

v  Mortality rates associated with sepsis

v  30-50% for severe sepsis

v  50-60% for septic shock

v  Severe sepsis is the leading cause of death in the non-coronary ICU

v  Sepsis kills approximately 1,400 people worldwide every day

v  2013 NYS DOH issues a mandate for all hospitals to produce clinical care guidelines

for evidence-based recognition and treatment of sepsis.

v  Adult and Pediatric treatment protocols for both ED and inpatient.

v  Education of hospital staff: Physician/Resident, RN, Pharm, Laboratory.

v  Data submission for public reporting of outcomes.

Page 8: Focus on Sepsis - SEIFEM

•  Sepsiscanleadtoshockandorganfailure,andisaleadingcauseofdeathintheUnitedStateswithamortalityrateofapproximately30%,almostdoublethemortalityrateofacutemyocardialinfarction,orheartattack.1

•  Sepsisisthemostexpensivehospital-treatedconditionintheUnitedStates–representingover$20.3billioninhealthcarecosts.2Over1.6millionpatientsintheUSalonearediagnosedwithsepsiseachyearandapproximately500,000diefromthisillness.3

•  Thehighcostoftreatingsepsisisprimarilydrivenbytheextendedhospitalizationofpatientswhichtypicallyincludesover7daysintheIntensiveCareUnit.4

CostofSepsis

1.JAntimicrobChemother2011;66Suppl2:ii11–ii23doi:10.1093/jac/dkq5152.HCUPStatisticalBrief#160.August2013.AgencyforHealthcareResearchandQuality,Rockville,MD.3.HCUPStatisticalBrief#122.October2011.AgencyforHealthcareResearchandQuality,Rockville,MD.4.Martin,J.B.,Wheeler,A.P.(2009).Approachtothepatientwithsepsis.Clin.ChestMed.,30(1),1-16.

Page 9: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 10: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 11: Focus on Sepsis - SEIFEM

Acontinuumofseveritydescribingthehostsystemicinflammatoryresponse

Page 12: Focus on Sepsis - SEIFEM

SIRS

²  SIRS–systemicinflammatoryresponsesyndrome²  Musthaveatleast2ofthefollowing:

²  Temperature>38.5ºCor<36ºC²  Heartrate>90beats/min²  Respiratoryrate>20breaths/minorPaCO2<32mmHg²  WBC>12,000cells/mm3,<4000cells/mm3,or>10%immature(band)forms

²  SIRSisthebody’sresponsetoinfection,inflammation,stress

Page 13: Focus on Sepsis - SEIFEM

SepsisandSevereSepsis

v  Sepsis–SIRS+suspectedorconfirmedinfection(documentedviaculturesorvisualizedviaphysicalexam/imaging)

v  SevereSepsis–Sepsis+atleastonesignoforganhypo-perfusionordysfunction

Areas of mottled skin Disseminated intravascular coagulation Capillary refill > 3 secs AKI UOP < 0.5cc/kg /hr ARDS or acute lung injury (ALI) Lactate > 2mmol /L Cardiac dysfunction on echo Altered mental status Plt < 100 Abnormal EEG Troponin Leak

Page 14: Focus on Sepsis - SEIFEM

SepticShock

²  SepticShock-Severesepsisplusoneofthefollowingconditions:–  MAP<60mmHg(<80mmHgifprevioushypertension)afteradequatefluidresuscitation

–  NeedforpressorstomaintainBPafterfluidresuscitation

–  Adequatefluidresuscitation=40to60mL/kgsalinesolution(NS5L-10L)

–  Lactate>4mmol/L

Page 15: Focus on Sepsis - SEIFEM

15

SevereSepsis

RelationshipBetweenSIRS,SepsisandSevereSepsis

BoneRCetal.Chest.1992;101:1644-55.

Trauma

Infection

SepsisOther

Pancreatitis

Burns

SIRS

Page 16: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 17: Focus on Sepsis - SEIFEM

PredisposingUnderlyingDiseases

²  Heartdisease-rheumaticorcongenital²  Splenectomy²  Intraabdominalsepsis²  Septicabortionorpelvicinfection²  Intravenousdrugabuse²  Immunocompromised

Page 18: Focus on Sepsis - SEIFEM

OrganismsResponsibleforSepticShockinRelationtoHostFactors

Asplenia EncapsulatedorganismsPneumococcusspp.,Haemophilusinfluenzae,Neisseriameningtidis,CapnocytophagiacanimorsusBabesiosis

Cirrhosis Vibrio,Yersinia,andSalmonellaspp.,otherGram-negativerods(GNRs),encapsulatedorganisms

Alcoholism Klebsiellaspp.,pnemococcus

Page 19: Focus on Sepsis - SEIFEM

Diabetes MucormycosisandPseudomonasssp.malignantexternalotitis,Escherichiacoli

Steroids Tuberculosis,fungi,herpesvirusNeutropenia EntericGNR,Pseudomonas,Aspergillus,

Candida,andMucorspp.,Staphylococcusaureus

T-cellabnortmalities

Listeria,Salmonella,andMycobacteriaspp.,herpesvirusgroup(herpessimplexvirus,cytomegalovirus,varicellazostervirus)

Page 20: Focus on Sepsis - SEIFEM

TheEpidemiologyofSepsisintheUnitedStatesNumberofcasesofsepsisintheUnitedStates,accordingtothecausativeorganism,1979-2000

NEnglJMed2003;348:1546-1554

Page 21: Focus on Sepsis - SEIFEM

EmergenceofGram-NegativeOrganisms

²  Antibioticpressureonnormalflora²  Useofinvasivedevices²  Immunesuppression

Page 22: Focus on Sepsis - SEIFEM

Resistancetothird-generationcephalosporinsEurope,2014K. pneumoniae E. coli

EARS-NET

Page 23: Focus on Sepsis - SEIFEM

History

²  Communityversushospital-acquired²  Priororcurrentmedications²  Recentmanipulationsorsurgery²  Underlyingdiseases²  Travelhistory

Page 24: Focus on Sepsis - SEIFEM
Page 25: Focus on Sepsis - SEIFEM

Sourcesofsepsis

v  Respiratory 38%v  Urinarytract 21%v  Intra-abdominal16.5%v  CRBSI 2.3%v  Device 1.3%v  CNS 0.8%v  Others 11.3%

Page 26: Focus on Sepsis - SEIFEM

Non tunneled CVC extraluminal colonization intraluminal contamination

Tunneled CVC

intraluminal infection

Candida Staphylococcus

Page 27: Focus on Sepsis - SEIFEM

Themainproblemarenosocomialinfections!!

Page 28: Focus on Sepsis - SEIFEM

GI tractGI tract

insult

injury

translocation

infection

antibiotics

selection

Normalcommensalflora

Disease

Centralvenouscatheter

Candidaandbacterialspecies

Page 29: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 30: Focus on Sepsis - SEIFEM
Page 31: Focus on Sepsis - SEIFEM
Page 32: Focus on Sepsis - SEIFEM

SepsisPathogenesis

Unbalanced Immune Reaction

Tissue Factor

Procoagulant State

Microvascular Thrombosis

Mediators of Inflammation

ROS

Vasodilation Capillary Leak

DIC

Page 33: Focus on Sepsis - SEIFEM

BacterialcomponentsinthepathogenesisofSepticShock

BacterialcomponentsSourceEndotoxin(LPS,lipidA) Allgram-bacteriaPeptidoglycan Allbacteria

Lipoteichoicacid Gram+bacteriaPore-formingExotoxins S.aureus,S.pyogenes

E.coliSuperantigens S.aureus,S.pyogenesEnzymes S.pyogenes,C.perfringens

Page 34: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 35: Focus on Sepsis - SEIFEM

ClinicalManifestations

²  Fever,chills,hypotension²  Hypothermia,especiallyintheelderly²  Hyperventilation-respiratoryalkalosis²  Diaphoresis,apprehension,changeinmentalstatus

Page 36: Focus on Sepsis - SEIFEM

Skin

v Furuncles,cellulitis,bullouslesionsv  Intravenoussites,phlebitisv Erythemamultiformev Ecchymoticorpurpuriclesionsv DIC,petechiaev Ecthymagangrenosumv Purpurafulminans

Page 37: Focus on Sepsis - SEIFEM

CardiovascularSigns

v “Warmshock”-↑CO,↓SVRv “Coldshock”-↓CO,↑SVRv Anaerobicmetabolism-lacticacidemia

Page 38: Focus on Sepsis - SEIFEM

PulmonarySigns

v  Tachypneav  Hyperventilation,respiratoryalkalosisv  ARDS,respiratoryfailurev  Ventilation-perfusionmismatchv  Widenedalveolar-arterialoxygengradientv  Reducedlungcompliance

Page 39: Focus on Sepsis - SEIFEM

RenalandGastrointestinalSigns

v  Acutetubularnecrosis,oliguria,anuriav  UpperGIbleedingv  Cholestaticjaundicev  Increasedtransaminaselevelsv  Hypoglycemia

Page 40: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 41: Focus on Sepsis - SEIFEM

Sepsisiscurrentlydiagnosedusingclinicaldefinitionscombinedwith

cultureresults

Page 42: Focus on Sepsis - SEIFEM

Timeisacrucialpoint!!

Page 43: Focus on Sepsis - SEIFEM

DiagnosticstrategiesforrapididentificationofBSIs

AutomatedinstrumentsBloodcultures

Detectionofmicrobialgrowth

Time

ID/AST

Culture-basedmethods

Gramstaining

MALDI-TOFMS MolecularmethodstointegrateMALDIandto

detectresistancedeterminants

AST

Infectiousdiseaseconsultant

BSI,bloodstreaminfection;ID,identification;AST,antimicrobialsusceptibilitytesting;MALDI-TOFMS,matrix-assistedlaserdesorptionionizationtime-of-flightmassspectrometry

Infectiousdisease

consultant

Page 44: Focus on Sepsis - SEIFEM
Page 45: Focus on Sepsis - SEIFEM

RoleofProcalcitonininsepsis²  Alternative(cytokine-like)pathwayduringsepsis:‘Hormokine’²  Bacterialtoxins(gran+/gram-)andcytokinesstimulateproductionof

Procalcitonininallparenchymaltissues²  Thisprocesscanbeattenuatedorblockedduringviralinfectionbyinterferones.²  NonendocrinetissueieLiver,Lung,Brainetc.donothaveendocrinegranules

wherecalcitonincanbestored.²  PCTisimmediatelyreleasedintothebloodstream

Page 46: Focus on Sepsis - SEIFEM

PCT

²  Hasbactericidalproperties²  Presentinallmammalstested²  Probablywasanearlyhostdefenseagainstinfection

²  Replacedbymorerobustdefensessuchasantibodysystemandenhancedleukocytedefenses

²  Mostimportant,perhaps,indefendingthebodyagainstinvasionofbacteriaduringfeeding.

Page 47: Focus on Sepsis - SEIFEM

•  Howcanweusethiscellularsignalofinfectioninthemanagementofbothsepticandnonsepticpatients

•  Goals

–  Provideantibiotictherapytoptswhoneeditassoonaspossible–  Avoidantibioticprescriptiontothosewithoutinfection–  Dobothwithastronglikelihoodofbeingcorrect,atleastasgoodasothermarkerssuchasWBC,bands,fever,CRP

Page 48: Focus on Sepsis - SEIFEM

PCTkineticsprovideimportantinformationonprognosisofsepsispatients

•  Clinical symptoms alone are often insufficient for early and accurate diagnosis •  PCT levels, can be observed within 3-6 hours after an infectious challenge with a

peak - up to 1000 ng/ml - after 6-12 hrs. Half-life: ~24hrs •  Specific to bacterial origin of infection and reflects the severity of the infection

Brunkhorst FM et al., Intens. Care Med (1998) 24: 888-892

Page 49: Focus on Sepsis - SEIFEM

Harbarth S et.al. AM J Resp Crit Care Med. 2001; 164:396-402

WhenPCTisusedasareference,thesensitivityandspecificityofsepsisdiagnosiscanbesignificantlyincreasedcomparedwithconventionalclinicalparameters.

Sensitivity:94%Specificity:77%

Adding PCT results to clinical assessment improves the accuracy of the early clinical diagnosis of sepsis

Page 50: Focus on Sepsis - SEIFEM

C-ReactiveProtein(CRP)

v  Anadditionalinflammatorymarkeravailableforsepsisscreening

v  AriseintheplasmaconcentartionofCRPinabsenceofothernon-infectiouscausesofinflammation(i.e.trauma,surgery,etc)maybesuggestiveofinfection

v  SevereliverdiseasemayreducethelevationofCRP.Intheseindivuduals,diagnosisofsepsisshouldnotbeexcludedbasedonlowerCRP

Page 51: Focus on Sepsis - SEIFEM

Lactate

•  Thebody’senergyneedsmainlymetbyaerobicmetabolism,whichrequiredoxygen

•  Ifthereisalackofoxygenitreverttoanerobicmetabolismwhichlacticacidisproduct

•  ThismayleadtoacidosiswithadecreaseofpH

•  EvidenceisclearthatLactatelevelsarepredictiveofdeathandMODS

•  Clearanceoflactateisassociatedwithimprovedsurvival•  Algorithmsofcarebasedonlactateclearanceappearto

workaswellorbetterthanotherapproaches.

Page 52: Focus on Sepsis - SEIFEM
Page 53: Focus on Sepsis - SEIFEM
Page 54: Focus on Sepsis - SEIFEM

Simon L. et al. Clin Infect Dis. 2004; 39:206-217.

AddingPCTresultstoclinicalassessmentimprovestheaccuracyoftheearlyclinicaldiagnosisofsepsis

•  PCTlevelsaccuratelydifferentiatesepsisfromnoninfectiousinflammation*•  PCThasbeendemonstratedtobethebestmarkerfordifferentiatingpatientswithsepsisfromthosewith

systemicinflammatoryreactionnotrelatedtoinfectiouscause

Sensitivity:89%Specificity:94%

NPV:90%PPV:94%

Page 55: Focus on Sepsis - SEIFEM
Page 56: Focus on Sepsis - SEIFEM

TCI, time to culture-based identification results ; TDI, time to direct identification results.

Timetoidentification

v  Themediantimetopositivitywas12.2hours(IQR:8.2-17.5),rangingfrom10.4h(IQR:7-15.1)forGram-negativebacteria,to15.2h(IQR:10.3-18.5)forGram-positiveisolates.Itwas16.4h(IQR:10.3-28)foryeastsand10.5h(IQR:6-16)forpolymicrobialcultures.

v  Themediantimetoidentificationforthedirectmethodwas19.5hours(IQRs:14.3-26.5h)(range:17.2hforGram-negativesto21.5hforgram-positivesandyeasts)andthatforthecomparisonculture-basedmethodwas41.7h(IQRs,35.5-53h)

020

40

60

80

100

hours

Gram-negative Gram-positive Yeast mixed

TCI TDI

Page 57: Focus on Sepsis - SEIFEM

Using our IPF% reference normal range [IPF% 2.39% (0.8-5.1)], a significantly (p<0.0001) higher level of IPF% in samples with positive BC [IPF% 4.86% (2.4-15.8)] than in negative

samples [IPF% 1.79% (0.5-4.7)] was found Increased IPF% significantly correlates with BCs positivity.

Page 58: Focus on Sepsis - SEIFEM

v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv  Laboratoryv Outcomeandtreatment

Page 59: Focus on Sepsis - SEIFEM
Page 60: Focus on Sepsis - SEIFEM

FactorsAssociatedwithHighestMortality

v Respiratory>abdominal>urinaryv Nosocomialinfectionv Hypotension,anuriav  Isolationofenterococciorfungiv Gram-negativebacteremia,polymicrobialv Bodytemperaturelowerthan38°Cv Agegreaterthan40v Underlyinghematologicalmalignancy

Page 61: Focus on Sepsis - SEIFEM

SevereSepsisRecommendations

AdultandPediatricEvidence-basedStudies

1.   EarlyDetection2.   EarlyTreatment

•  SepsisResuscitationBundle

3. Monitorreliabilityandoutcomes

Page 62: Focus on Sepsis - SEIFEM

Earlyantibioticsaregood

Author N Setting Mediantime(mins)

Oddsratiofordeath

GaieskiCCM2010;38;1045-53

261 ED,USA(shock)

119 0.30(1sthourvsalltimes)

DanielsEmergMedJ2010;doi:10.1136

567 Wholehospital,UK

121 0.62(1sthourvsalltimes)

KumarCCM2006;34(6):1589-1596

2154 ED,Canada(shock)

360 0.59(1st3hoursvsdelayed)

AppelboamCCM2010;14(Suppl1):50

375 Wholehospital,UK

240 0.74(1st3hoursvsdelayed)

LevyCCM2010;38(2):1-8

15022 Multi-centre 0.86(1st3hoursvsdelayed)

Page 63: Focus on Sepsis - SEIFEM

Rapiddetectionofsepsishaveagreat

impactonthesurvivalofpatients

FungalinfectionsMorrelletal.,AAC,2005

BacterialsepsisKumaretal.,Clin.CareMed.,2006

Page 64: Focus on Sepsis - SEIFEM

VariablesindependentlyassociatedwithmortalityofBSIs.Logisticregressionanalysis

v  inadequateinitialantimicrobialtherapy(OR,6.28;95%CI,3.18to12.42;P<0.001)

v  unidentifiedprimaryinfectionsite(OR,2.69;95%CI,1.38to5.27;P=0.004).

Tumbarelloetal.AntimicrobAgentsChemother2007

Page 65: Focus on Sepsis - SEIFEM

InappropriateAntimicrobialTherapy:ImpactonMortality

Kollefetal:Chest2002

0

100

200

300

400

500

600

No.In

fected

Pa

tients

42.0%mortality

17.7%mortality

RelativeRisk=2.37(95%C.I.1.83-3.08;P<.001)

#Deaths

#Survivors

InappropriateTherapy

AppropriateTherapy

Page 66: Focus on Sepsis - SEIFEM

N Engl J Med, Vol. 347, No. 13·September 26, 2002

Mortality

Page 67: Focus on Sepsis - SEIFEM

Septic Shock Outcomes for Patients on Hospital Wards versus

ICU’s •  Wardpatients: DelaysinICUtransfer(67mins.) IVfluidboluses(27vs15mins.) Inotropicagents(310vs22.5mins)

•  Mortality: Wards(70%)vsICUs(39%) ApacheIIscores(18.5vs24) Candidemia

JSLunberg,Crit.CareMed.1998